Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urologic Neoplasms 2Stomach Neoplasms 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Obesity 1Neuromuscular Blockade 1Myasthenia Gravis 1Endobronchial Metastases 1Delayed Emergence from Anesthesia 1Brain Neoplasms 1

Interventions

rozanolixizumab 5zilucoplan 4eculizumab 4Rituximab 4Immunoglobulins, Intravenous 4efgartigimod alfa 3Tacrolimus 3Mycophenolic Acid 3Hizentra 3HBM9161 3Data Collection 2Azathioprine 2tofacitinib 1telitacicept 1ravulizumab 1iscalimab 1gamma-Globulins 1apraclonidine 1Thymectomy 1Telemedicine 1Sugammadex 1Sodium Chloride 1Pyridostigmine Bromide 1Prednisone 1Prednisolone 1Plasmapheresis 1Plasma Exchange 1Neurofeedback 1Neostigmine 1Muscle Stretching Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Myasthenia Gravis × Sugammadex × Clear all
NCT06436768 2025-04-02

Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis

Beijing Tongren Hospital

Phase NA Completed
62 enrolled

Myasthenia Gravis, Delayed Emergence from Anesthesia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡